Biotech entity
All 1 tracked stories fall under one category: pharma. The tracked stories average 2 original sources each. Hologic, Inc. appears in 1 tracked Biotech story from March 15, 2026.
Last mentioned: Mar 15, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: pharma. The tracked stories average 2 original sources each. Hologic, Inc. appears in 1 tracked Biotech story from March 15, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 4 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Short Interest Spike
Data reveals a 71.7% expansion in short interest for HOLX shares.
Shareholder Meeting
Company files Item 5.07 regarding shareholder voting results.
Earnings Update
Hologic releases results of operations and financial condition in SEC filing.
Hologic, Inc. (NASDAQ: HOLX) has experienced a dramatic 71.7% increase in short interest, signaling a significant shift in market sentiment toward the medical technology leader. This surge reflects growing investor caution regarding the company's growth trajectory in a post-pandemic diagnostic landscape.
Hologic, Inc. is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
